The FDA approved the Vabysmo 6-mg single-dose prefilled syringe for the treatment of wet age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion ...

Trends, opportunities and forecast in prefilled syringe market to 2027 by material (glass-based and plastic-based), product type (conventional and safety), design (single chamber, dual chamber ...

The global prefilled syringe market is growing at a CAGR of 10.6% from 2022 to 2030.Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Prefilled syringes (PFS) are the most recent aids for ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign.. The “Treatment MY ...

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a prefilled syringe version of Vyvgart—also known as efgartigimod ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials.

The FDA’s latest approval of the therapy was based on data from studies evaluating the pre-filled syringe version’s bioequivalence to Vyvgart Hytrulo in a vial. Also supporting the decision were ...

Hikma is introducing succinylcholine chloride injection in prefilled syringe form. The 100 mg/5 ml PFS is the first Food and Drug Administration approved PFS for this product to be introduced in ...